The global depository receipt of Ranbaxy Laboratories rose by 1.23 per cent to $11.51 during early trades on Monday, November 25.
Despite this, the Skindia GDR Index, which represents the global depository receipts and American depositary receipts of 15 actively traded companies, remained more or less unchanged at 487.55 at 11:30 AM GMT.
Ranbaxy has a weightage of more than 6 per cent in the index.
Also Read
The index premium marginally decreased 1.15 per cent to 12.58 per cent. Among Indian global depository receipts, there were 12 gainers, 2 losers and 31 remained unchanged.
Prominent gainers were Mahindra & Mahindra, which was up 5.50 per cent, SAIL (up 4.44 per cent) and Tata Tea (up by 3.91 per cent).
The losers were Indian Hotels (down by 3.15 per cent) and IPCL (down by 0.60 per cent). The index rose sharply by 2.65 per cent to 485.75 on November 22 compared with the preceding day
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app